Microbix Biosystems Inc (TSX:MBX). CEO Cameron (NYSE:CAM) Groome joined Proactive to discuss how the Mississauga, Onatario-based biotechnology group's suite of quality control for diagnostics products are 'gaining increasing success' for diagnostic manufactures and clinical laboratories.
Groome says many leading diagnostics companies have been citing or recommending Microbix's products for its users.
He adds the group is completing work on controls for the Delta variant of the coronavirus, with controls already in place for the original strain, the Brazilian, South African, and UK strain.